Vision loss in patients with giant cell arteritis treated with tocilizumab

Vision loss in patients with giant cell arteritis treated with tocilizumab

Abstract Objectives Giant cell arteritis (GCA) may lead to vision loss. To what extent tocilizumab (TCZ) is able to prevent vision loss is unknown. The aim was to analyze the occurrence of vision loss in a large GCA cohort treated with TCZ. Methods In this observational monocentric study, GCA patien...

Full description

Bibliographic Details
Main Authors: Jennifer Amsler, Iveta Kysela, Christoph Tappeiner, Luca Seitz, Lisa Christ, Godehard Scholz, Odile Stalder, Florian Kollert, Stephan Reichenbach, Peter M. Villiger
Format: Article
Language:English
Published: BMC 2021-03-01
Series:Arthritis Research & Therapy
Subjects:
Giant cell arteritis
Tocilizumab
Glucocorticoids
Anterior ischemic optic neuropathy (AION)
Vision loss
Online Access:https://doi.org/10.1186/s13075-021-02480-4

Internet

https://doi.org/10.1186/s13075-021-02480-4

Similar Items